nodes	percent_of_prediction	percent_of_DWPC	metapath
Enalapril—Captopril—MMP2—liver cancer	0.0151	0.318	CrCbGaD
Enalapril—Captopril—F2—liver cancer	0.0129	0.272	CrCbGaD
Enalapril—Captopril—MMP9—liver cancer	0.00994	0.209	CrCbGaD
Enalapril—Benazepril—MTHFR—liver cancer	0.00399	0.0841	CrCbGaD
Enalapril—Anaphylactic shock—Sorafenib—liver cancer	0.00285	0.00354	CcSEcCtD
Enalapril—Shock—Sorafenib—liver cancer	0.00281	0.00349	CcSEcCtD
Enalapril—Thrombocytopenia—Sorafenib—liver cancer	0.00279	0.00347	CcSEcCtD
Enalapril—Blood urea increased—Epirubicin—liver cancer	0.00279	0.00346	CcSEcCtD
Enalapril—Neck pain—Doxorubicin—liver cancer	0.00277	0.00344	CcSEcCtD
Enalapril—Musculoskeletal pain—Doxorubicin—liver cancer	0.00277	0.00344	CcSEcCtD
Enalapril—Captopril—ALB—liver cancer	0.00276	0.0582	CrCbGaD
Enalapril—Pulmonary embolism—Doxorubicin—liver cancer	0.00273	0.0034	CcSEcCtD
Enalapril—Dry eye—Epirubicin—liver cancer	0.00273	0.00339	CcSEcCtD
Enalapril—Anorexia—Sorafenib—liver cancer	0.00272	0.00338	CcSEcCtD
Enalapril—Hyperkalaemia—Doxorubicin—liver cancer	0.00269	0.00334	CcSEcCtD
Enalapril—Melaena—Doxorubicin—liver cancer	0.00267	0.00332	CcSEcCtD
Enalapril—Influenza like illness—Doxorubicin—liver cancer	0.00265	0.0033	CcSEcCtD
Enalapril—Pulmonary oedema—Epirubicin—liver cancer	0.00263	0.00327	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Sorafenib—liver cancer	0.0026	0.00323	CcSEcCtD
Enalapril—Blood urea increased—Doxorubicin—liver cancer	0.00258	0.00321	CcSEcCtD
Enalapril—Dyspnoea—Sorafenib—liver cancer	0.00254	0.00316	CcSEcCtD
Enalapril—Dry eye—Doxorubicin—liver cancer	0.00252	0.00314	CcSEcCtD
Enalapril—Dyspepsia—Sorafenib—liver cancer	0.00251	0.00312	CcSEcCtD
Enalapril—Decreased appetite—Sorafenib—liver cancer	0.00248	0.00308	CcSEcCtD
Enalapril—Fatigue—Sorafenib—liver cancer	0.00246	0.00305	CcSEcCtD
Enalapril—Photosensitivity—Epirubicin—liver cancer	0.00244	0.00303	CcSEcCtD
Enalapril—Constipation—Sorafenib—liver cancer	0.00244	0.00303	CcSEcCtD
Enalapril—Pulmonary oedema—Doxorubicin—liver cancer	0.00243	0.00302	CcSEcCtD
Enalapril—Hepatic failure—Epirubicin—liver cancer	0.00239	0.00296	CcSEcCtD
Enalapril—Gastrointestinal pain—Sorafenib—liver cancer	0.00233	0.0029	CcSEcCtD
Enalapril—Hot flush—Epirubicin—liver cancer	0.00229	0.00285	CcSEcCtD
Enalapril—Dermatitis exfoliative—Epirubicin—liver cancer	0.00227	0.00282	CcSEcCtD
Enalapril—Menopausal symptoms—Epirubicin—liver cancer	0.00227	0.00282	CcSEcCtD
Enalapril—Urticaria—Sorafenib—liver cancer	0.00227	0.00281	CcSEcCtD
Enalapril—Photosensitivity—Doxorubicin—liver cancer	0.00226	0.00281	CcSEcCtD
Enalapril—Abdominal pain—Sorafenib—liver cancer	0.00225	0.0028	CcSEcCtD
Enalapril—Body temperature increased—Sorafenib—liver cancer	0.00225	0.0028	CcSEcCtD
Enalapril—Anaphylactoid reaction—Epirubicin—liver cancer	0.00222	0.00275	CcSEcCtD
Enalapril—Hepatic failure—Doxorubicin—liver cancer	0.00221	0.00274	CcSEcCtD
Enalapril—Hypoglycaemia—Epirubicin—liver cancer	0.0022	0.00273	CcSEcCtD
Enalapril—Cerebrovascular accident—Epirubicin—liver cancer	0.00219	0.00272	CcSEcCtD
Enalapril—Hyponatraemia—Epirubicin—liver cancer	0.00215	0.00267	CcSEcCtD
Enalapril—Pain in extremity—Epirubicin—liver cancer	0.00214	0.00266	CcSEcCtD
Enalapril—Hot flush—Doxorubicin—liver cancer	0.00212	0.00263	CcSEcCtD
Enalapril—Dermatitis exfoliative—Doxorubicin—liver cancer	0.0021	0.00261	CcSEcCtD
Enalapril—Menopausal symptoms—Doxorubicin—liver cancer	0.0021	0.00261	CcSEcCtD
Enalapril—Hypersensitivity—Sorafenib—liver cancer	0.0021	0.00261	CcSEcCtD
Enalapril—Face oedema—Epirubicin—liver cancer	0.00207	0.00257	CcSEcCtD
Enalapril—Anaphylactoid reaction—Doxorubicin—liver cancer	0.00205	0.00255	CcSEcCtD
Enalapril—Asthenia—Sorafenib—liver cancer	0.00205	0.00254	CcSEcCtD
Enalapril—Nateglinide—PPARG—liver cancer	0.00204	0.043	CrCbGaD
Enalapril—Cardiac arrest—Epirubicin—liver cancer	0.00204	0.00253	CcSEcCtD
Enalapril—Hypoglycaemia—Doxorubicin—liver cancer	0.00203	0.00253	CcSEcCtD
Enalapril—Cerebrovascular accident—Doxorubicin—liver cancer	0.00202	0.00251	CcSEcCtD
Enalapril—Pruritus—Sorafenib—liver cancer	0.00202	0.00251	CcSEcCtD
Enalapril—Ataxia—Epirubicin—liver cancer	0.00202	0.0025	CcSEcCtD
Enalapril—Blood creatinine increased—Epirubicin—liver cancer	0.00201	0.0025	CcSEcCtD
Enalapril—Hyponatraemia—Doxorubicin—liver cancer	0.00199	0.00247	CcSEcCtD
Enalapril—Pain in extremity—Doxorubicin—liver cancer	0.00198	0.00246	CcSEcCtD
Enalapril—Dry skin—Epirubicin—liver cancer	0.00197	0.00244	CcSEcCtD
Enalapril—Orthostatic hypotension—Epirubicin—liver cancer	0.00196	0.00243	CcSEcCtD
Enalapril—Diarrhoea—Sorafenib—liver cancer	0.00195	0.00242	CcSEcCtD
Enalapril—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.00193	0.0024	CcSEcCtD
Enalapril—Nasopharyngitis—Epirubicin—liver cancer	0.00192	0.00238	CcSEcCtD
Enalapril—Face oedema—Doxorubicin—liver cancer	0.00192	0.00238	CcSEcCtD
Enalapril—Alanine aminotransferase increased—Epirubicin—liver cancer	0.00189	0.00235	CcSEcCtD
Enalapril—Cardiac arrest—Doxorubicin—liver cancer	0.00189	0.00234	CcSEcCtD
Enalapril—Dizziness—Sorafenib—liver cancer	0.00189	0.00234	CcSEcCtD
Enalapril—Ataxia—Doxorubicin—liver cancer	0.00187	0.00232	CcSEcCtD
Enalapril—Blood creatinine increased—Doxorubicin—liver cancer	0.00186	0.00231	CcSEcCtD
Enalapril—Asthma—Epirubicin—liver cancer	0.00185	0.0023	CcSEcCtD
Enalapril—Influenza—Epirubicin—liver cancer	0.00185	0.0023	CcSEcCtD
Enalapril—Dysphagia—Epirubicin—liver cancer	0.00185	0.0023	CcSEcCtD
Enalapril—Eosinophilia—Epirubicin—liver cancer	0.00184	0.00228	CcSEcCtD
Enalapril—Dry skin—Doxorubicin—liver cancer	0.00182	0.00226	CcSEcCtD
Enalapril—Pancreatitis—Epirubicin—liver cancer	0.00182	0.00226	CcSEcCtD
Enalapril—Vomiting—Sorafenib—liver cancer	0.00181	0.00225	CcSEcCtD
Enalapril—Orthostatic hypotension—Doxorubicin—liver cancer	0.00181	0.00225	CcSEcCtD
Enalapril—Angina pectoris—Epirubicin—liver cancer	0.00181	0.00224	CcSEcCtD
Enalapril—Rash—Sorafenib—liver cancer	0.0018	0.00223	CcSEcCtD
Enalapril—Dermatitis—Sorafenib—liver cancer	0.0018	0.00223	CcSEcCtD
Enalapril—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.00179	0.00222	CcSEcCtD
Enalapril—Headache—Sorafenib—liver cancer	0.00179	0.00222	CcSEcCtD
Enalapril—Bronchitis—Epirubicin—liver cancer	0.00178	0.00221	CcSEcCtD
Enalapril—Nasopharyngitis—Doxorubicin—liver cancer	0.00177	0.0022	CcSEcCtD
Enalapril—Pancytopenia—Epirubicin—liver cancer	0.00176	0.00219	CcSEcCtD
Enalapril—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.00175	0.00217	CcSEcCtD
Enalapril—Dysuria—Epirubicin—liver cancer	0.00173	0.00215	CcSEcCtD
Enalapril—Neutropenia—Epirubicin—liver cancer	0.00173	0.00215	CcSEcCtD
Enalapril—Upper respiratory tract infection—Epirubicin—liver cancer	0.00172	0.00214	CcSEcCtD
Enalapril—Influenza—Doxorubicin—liver cancer	0.00171	0.00213	CcSEcCtD
Enalapril—Asthma—Doxorubicin—liver cancer	0.00171	0.00213	CcSEcCtD
Enalapril—Dysphagia—Doxorubicin—liver cancer	0.00171	0.00213	CcSEcCtD
Enalapril—Pollakiuria—Epirubicin—liver cancer	0.00171	0.00213	CcSEcCtD
Enalapril—Eosinophilia—Doxorubicin—liver cancer	0.0017	0.00211	CcSEcCtD
Enalapril—Nausea—Sorafenib—liver cancer	0.00169	0.0021	CcSEcCtD
Enalapril—Photosensitivity reaction—Epirubicin—liver cancer	0.00169	0.0021	CcSEcCtD
Enalapril—Pancreatitis—Doxorubicin—liver cancer	0.00168	0.00209	CcSEcCtD
Enalapril—Hyperglycaemia—Epirubicin—liver cancer	0.00167	0.00208	CcSEcCtD
Enalapril—Angina pectoris—Doxorubicin—liver cancer	0.00167	0.00207	CcSEcCtD
Enalapril—Pneumonia—Epirubicin—liver cancer	0.00166	0.00206	CcSEcCtD
Enalapril—Bronchitis—Doxorubicin—liver cancer	0.00165	0.00205	CcSEcCtD
Enalapril—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.00164	0.00204	CcSEcCtD
Enalapril—Pancytopenia—Doxorubicin—liver cancer	0.00163	0.00202	CcSEcCtD
Enalapril—Renal failure—Epirubicin—liver cancer	0.00162	0.00202	CcSEcCtD
Enalapril—Neuropathy peripheral—Epirubicin—liver cancer	0.00162	0.00201	CcSEcCtD
Enalapril—Stomatitis—Epirubicin—liver cancer	0.00161	0.002	CcSEcCtD
Enalapril—Jaundice—Epirubicin—liver cancer	0.00161	0.002	CcSEcCtD
Enalapril—Urinary tract infection—Epirubicin—liver cancer	0.00161	0.002	CcSEcCtD
Enalapril—Conjunctivitis—Epirubicin—liver cancer	0.00161	0.002	CcSEcCtD
Enalapril—Dysuria—Doxorubicin—liver cancer	0.0016	0.00199	CcSEcCtD
Enalapril—Neutropenia—Doxorubicin—liver cancer	0.0016	0.00199	CcSEcCtD
Enalapril—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00159	0.00198	CcSEcCtD
Enalapril—Pollakiuria—Doxorubicin—liver cancer	0.00158	0.00197	CcSEcCtD
Enalapril—Photosensitivity reaction—Doxorubicin—liver cancer	0.00157	0.00194	CcSEcCtD
Enalapril—Epistaxis—Epirubicin—liver cancer	0.00156	0.00194	CcSEcCtD
Enalapril—Sinusitis—Epirubicin—liver cancer	0.00155	0.00193	CcSEcCtD
Enalapril—Hyperglycaemia—Doxorubicin—liver cancer	0.00155	0.00192	CcSEcCtD
Enalapril—Agranulocytosis—Epirubicin—liver cancer	0.00154	0.00192	CcSEcCtD
Enalapril—Pneumonia—Doxorubicin—liver cancer	0.00154	0.00191	CcSEcCtD
Enalapril—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.00152	0.00188	CcSEcCtD
Enalapril—Bradycardia—Epirubicin—liver cancer	0.00151	0.00188	CcSEcCtD
Enalapril—Renal failure—Doxorubicin—liver cancer	0.0015	0.00187	CcSEcCtD
Enalapril—Neuropathy peripheral—Doxorubicin—liver cancer	0.0015	0.00186	CcSEcCtD
Enalapril—Stomatitis—Doxorubicin—liver cancer	0.00149	0.00185	CcSEcCtD
Enalapril—Jaundice—Doxorubicin—liver cancer	0.00149	0.00185	CcSEcCtD
Enalapril—Urinary tract infection—Doxorubicin—liver cancer	0.00149	0.00185	CcSEcCtD
Enalapril—Conjunctivitis—Doxorubicin—liver cancer	0.00149	0.00185	CcSEcCtD
Enalapril—Hepatitis—Epirubicin—liver cancer	0.00148	0.00184	CcSEcCtD
Enalapril—Pharyngitis—Epirubicin—liver cancer	0.00147	0.00183	CcSEcCtD
Enalapril—Epistaxis—Doxorubicin—liver cancer	0.00144	0.00179	CcSEcCtD
Enalapril—Sinusitis—Doxorubicin—liver cancer	0.00143	0.00178	CcSEcCtD
Enalapril—Visual impairment—Epirubicin—liver cancer	0.00143	0.00178	CcSEcCtD
Enalapril—Agranulocytosis—Doxorubicin—liver cancer	0.00143	0.00177	CcSEcCtD
Enalapril—Erythema multiforme—Epirubicin—liver cancer	0.0014	0.00174	CcSEcCtD
Enalapril—Bradycardia—Doxorubicin—liver cancer	0.0014	0.00174	CcSEcCtD
Enalapril—Tinnitus—Epirubicin—liver cancer	0.00138	0.00172	CcSEcCtD
Enalapril—Flushing—Epirubicin—liver cancer	0.00138	0.00171	CcSEcCtD
Enalapril—Hepatitis—Doxorubicin—liver cancer	0.00137	0.0017	CcSEcCtD
Enalapril—Pharyngitis—Doxorubicin—liver cancer	0.00136	0.00169	CcSEcCtD
Enalapril—Arrhythmia—Epirubicin—liver cancer	0.00133	0.00165	CcSEcCtD
Enalapril—Visual impairment—Doxorubicin—liver cancer	0.00132	0.00164	CcSEcCtD
Enalapril—Alopecia—Epirubicin—liver cancer	0.00131	0.00163	CcSEcCtD
Enalapril—Erythema multiforme—Doxorubicin—liver cancer	0.0013	0.00161	CcSEcCtD
Enalapril—Erythema—Epirubicin—liver cancer	0.00129	0.0016	CcSEcCtD
Enalapril—Tinnitus—Doxorubicin—liver cancer	0.00128	0.00159	CcSEcCtD
Enalapril—Flushing—Doxorubicin—liver cancer	0.00127	0.00158	CcSEcCtD
Enalapril—Flatulence—Epirubicin—liver cancer	0.00127	0.00158	CcSEcCtD
Enalapril—Tension—Epirubicin—liver cancer	0.00127	0.00157	CcSEcCtD
Enalapril—Dysgeusia—Epirubicin—liver cancer	0.00126	0.00157	CcSEcCtD
Enalapril—Nervousness—Epirubicin—liver cancer	0.00125	0.00156	CcSEcCtD
Enalapril—Back pain—Epirubicin—liver cancer	0.00125	0.00155	CcSEcCtD
Enalapril—Muscle spasms—Epirubicin—liver cancer	0.00124	0.00154	CcSEcCtD
Enalapril—Arrhythmia—Doxorubicin—liver cancer	0.00123	0.00152	CcSEcCtD
Enalapril—Vision blurred—Epirubicin—liver cancer	0.00122	0.00151	CcSEcCtD
Enalapril—Alopecia—Doxorubicin—liver cancer	0.00121	0.00151	CcSEcCtD
Enalapril—Erythema—Doxorubicin—liver cancer	0.00119	0.00148	CcSEcCtD
Enalapril—Anaemia—Epirubicin—liver cancer	0.00119	0.00148	CcSEcCtD
Enalapril—Agitation—Epirubicin—liver cancer	0.00119	0.00147	CcSEcCtD
Enalapril—Flatulence—Doxorubicin—liver cancer	0.00118	0.00146	CcSEcCtD
Enalapril—Tension—Doxorubicin—liver cancer	0.00117	0.00146	CcSEcCtD
Enalapril—Dysgeusia—Doxorubicin—liver cancer	0.00117	0.00145	CcSEcCtD
Enalapril—Nervousness—Doxorubicin—liver cancer	0.00116	0.00144	CcSEcCtD
Enalapril—Vertigo—Epirubicin—liver cancer	0.00116	0.00144	CcSEcCtD
Enalapril—Syncope—Epirubicin—liver cancer	0.00116	0.00144	CcSEcCtD
Enalapril—Leukopenia—Epirubicin—liver cancer	0.00116	0.00144	CcSEcCtD
Enalapril—Back pain—Doxorubicin—liver cancer	0.00116	0.00144	CcSEcCtD
Enalapril—Muscle spasms—Doxorubicin—liver cancer	0.00115	0.00143	CcSEcCtD
Enalapril—Palpitations—Epirubicin—liver cancer	0.00114	0.00142	CcSEcCtD
Enalapril—Loss of consciousness—Epirubicin—liver cancer	0.00114	0.00141	CcSEcCtD
Enalapril—Cough—Epirubicin—liver cancer	0.00113	0.0014	CcSEcCtD
Enalapril—Vision blurred—Doxorubicin—liver cancer	0.00113	0.0014	CcSEcCtD
Enalapril—Anaemia—Doxorubicin—liver cancer	0.0011	0.00137	CcSEcCtD
Enalapril—Arthralgia—Epirubicin—liver cancer	0.0011	0.00137	CcSEcCtD
Enalapril—Chest pain—Epirubicin—liver cancer	0.0011	0.00137	CcSEcCtD
Enalapril—Myalgia—Epirubicin—liver cancer	0.0011	0.00137	CcSEcCtD
Enalapril—Agitation—Doxorubicin—liver cancer	0.0011	0.00136	CcSEcCtD
Enalapril—Discomfort—Epirubicin—liver cancer	0.00109	0.00135	CcSEcCtD
Enalapril—Dry mouth—Epirubicin—liver cancer	0.00108	0.00134	CcSEcCtD
Enalapril—Vertigo—Doxorubicin—liver cancer	0.00107	0.00133	CcSEcCtD
Enalapril—Syncope—Doxorubicin—liver cancer	0.00107	0.00133	CcSEcCtD
Enalapril—Leukopenia—Doxorubicin—liver cancer	0.00107	0.00133	CcSEcCtD
Enalapril—Confusional state—Epirubicin—liver cancer	0.00106	0.00132	CcSEcCtD
Enalapril—Palpitations—Doxorubicin—liver cancer	0.00106	0.00131	CcSEcCtD
Enalapril—Anaphylactic shock—Epirubicin—liver cancer	0.00105	0.00131	CcSEcCtD
Enalapril—Oedema—Epirubicin—liver cancer	0.00105	0.00131	CcSEcCtD
Enalapril—Loss of consciousness—Doxorubicin—liver cancer	0.00105	0.0013	CcSEcCtD
Enalapril—Cough—Doxorubicin—liver cancer	0.00104	0.0013	CcSEcCtD
Enalapril—Shock—Epirubicin—liver cancer	0.00104	0.00129	CcSEcCtD
Enalapril—Thrombocytopenia—Epirubicin—liver cancer	0.00103	0.00128	CcSEcCtD
Enalapril—Tachycardia—Epirubicin—liver cancer	0.00103	0.00128	CcSEcCtD
Enalapril—Hyperhidrosis—Epirubicin—liver cancer	0.00102	0.00127	CcSEcCtD
Enalapril—Chest pain—Doxorubicin—liver cancer	0.00102	0.00126	CcSEcCtD
Enalapril—Myalgia—Doxorubicin—liver cancer	0.00102	0.00126	CcSEcCtD
Enalapril—Arthralgia—Doxorubicin—liver cancer	0.00102	0.00126	CcSEcCtD
Enalapril—Discomfort—Doxorubicin—liver cancer	0.00101	0.00125	CcSEcCtD
Enalapril—Anorexia—Epirubicin—liver cancer	0.001	0.00125	CcSEcCtD
Enalapril—Dry mouth—Doxorubicin—liver cancer	0.000995	0.00124	CcSEcCtD
Enalapril—Hypotension—Epirubicin—liver cancer	0.000985	0.00122	CcSEcCtD
Enalapril—Confusional state—Doxorubicin—liver cancer	0.000983	0.00122	CcSEcCtD
Enalapril—Anaphylactic shock—Doxorubicin—liver cancer	0.000975	0.00121	CcSEcCtD
Enalapril—Oedema—Doxorubicin—liver cancer	0.000975	0.00121	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00096	0.00119	CcSEcCtD
Enalapril—Shock—Doxorubicin—liver cancer	0.000959	0.00119	CcSEcCtD
Enalapril—Thrombocytopenia—Doxorubicin—liver cancer	0.000955	0.00119	CcSEcCtD
Enalapril—Insomnia—Epirubicin—liver cancer	0.000953	0.00118	CcSEcCtD
Enalapril—Tachycardia—Doxorubicin—liver cancer	0.000952	0.00118	CcSEcCtD
Enalapril—Paraesthesia—Epirubicin—liver cancer	0.000946	0.00118	CcSEcCtD
Enalapril—Hyperhidrosis—Doxorubicin—liver cancer	0.000943	0.00117	CcSEcCtD
Enalapril—Dyspnoea—Epirubicin—liver cancer	0.00094	0.00117	CcSEcCtD
Enalapril—Somnolence—Epirubicin—liver cancer	0.000937	0.00116	CcSEcCtD
Enalapril—Anorexia—Doxorubicin—liver cancer	0.00093	0.00115	CcSEcCtD
Enalapril—Dyspepsia—Epirubicin—liver cancer	0.000928	0.00115	CcSEcCtD
Enalapril—Decreased appetite—Epirubicin—liver cancer	0.000916	0.00114	CcSEcCtD
Enalapril—Hypotension—Doxorubicin—liver cancer	0.000911	0.00113	CcSEcCtD
Enalapril—Fatigue—Epirubicin—liver cancer	0.000909	0.00113	CcSEcCtD
Enalapril—Constipation—Epirubicin—liver cancer	0.000901	0.00112	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000888	0.0011	CcSEcCtD
Enalapril—Insomnia—Doxorubicin—liver cancer	0.000882	0.0011	CcSEcCtD
Enalapril—Paraesthesia—Doxorubicin—liver cancer	0.000876	0.00109	CcSEcCtD
Enalapril—Dyspnoea—Doxorubicin—liver cancer	0.000869	0.00108	CcSEcCtD
Enalapril—Feeling abnormal—Epirubicin—liver cancer	0.000869	0.00108	CcSEcCtD
Enalapril—Somnolence—Doxorubicin—liver cancer	0.000867	0.00108	CcSEcCtD
Enalapril—Gastrointestinal pain—Epirubicin—liver cancer	0.000862	0.00107	CcSEcCtD
Enalapril—Dyspepsia—Doxorubicin—liver cancer	0.000858	0.00107	CcSEcCtD
Enalapril—Decreased appetite—Doxorubicin—liver cancer	0.000848	0.00105	CcSEcCtD
Enalapril—Fatigue—Doxorubicin—liver cancer	0.000841	0.00104	CcSEcCtD
Enalapril—Urticaria—Epirubicin—liver cancer	0.000837	0.00104	CcSEcCtD
Enalapril—Constipation—Doxorubicin—liver cancer	0.000834	0.00104	CcSEcCtD
Enalapril—Body temperature increased—Epirubicin—liver cancer	0.000833	0.00103	CcSEcCtD
Enalapril—Abdominal pain—Epirubicin—liver cancer	0.000833	0.00103	CcSEcCtD
Enalapril—Feeling abnormal—Doxorubicin—liver cancer	0.000804	0.000998	CcSEcCtD
Enalapril—Gastrointestinal pain—Doxorubicin—liver cancer	0.000797	0.000991	CcSEcCtD
Enalapril—Hypersensitivity—Epirubicin—liver cancer	0.000776	0.000965	CcSEcCtD
Enalapril—Urticaria—Doxorubicin—liver cancer	0.000775	0.000962	CcSEcCtD
Enalapril—Body temperature increased—Doxorubicin—liver cancer	0.000771	0.000958	CcSEcCtD
Enalapril—Abdominal pain—Doxorubicin—liver cancer	0.000771	0.000958	CcSEcCtD
Enalapril—Nateglinide—ALB—liver cancer	0.000769	0.0162	CrCbGaD
Enalapril—Asthenia—Epirubicin—liver cancer	0.000756	0.000939	CcSEcCtD
Enalapril—Pruritus—Epirubicin—liver cancer	0.000746	0.000926	CcSEcCtD
Enalapril—Diarrhoea—Epirubicin—liver cancer	0.000721	0.000896	CcSEcCtD
Enalapril—Hypersensitivity—Doxorubicin—liver cancer	0.000718	0.000892	CcSEcCtD
Enalapril—Asthenia—Doxorubicin—liver cancer	0.0007	0.000869	CcSEcCtD
Enalapril—Dizziness—Epirubicin—liver cancer	0.000697	0.000866	CcSEcCtD
Enalapril—Pruritus—Doxorubicin—liver cancer	0.00069	0.000857	CcSEcCtD
Enalapril—Vomiting—Epirubicin—liver cancer	0.00067	0.000832	CcSEcCtD
Enalapril—Diarrhoea—Doxorubicin—liver cancer	0.000667	0.000829	CcSEcCtD
Enalapril—Rash—Epirubicin—liver cancer	0.000665	0.000825	CcSEcCtD
Enalapril—Dermatitis—Epirubicin—liver cancer	0.000664	0.000825	CcSEcCtD
Enalapril—Headache—Epirubicin—liver cancer	0.00066	0.00082	CcSEcCtD
Enalapril—Dizziness—Doxorubicin—liver cancer	0.000645	0.000801	CcSEcCtD
Enalapril—Nausea—Epirubicin—liver cancer	0.000626	0.000778	CcSEcCtD
Enalapril—Vomiting—Doxorubicin—liver cancer	0.00062	0.00077	CcSEcCtD
Enalapril—Rash—Doxorubicin—liver cancer	0.000615	0.000764	CcSEcCtD
Enalapril—Dermatitis—Doxorubicin—liver cancer	0.000614	0.000763	CcSEcCtD
Enalapril—Headache—Doxorubicin—liver cancer	0.000611	0.000759	CcSEcCtD
Enalapril—Nausea—Doxorubicin—liver cancer	0.000579	0.00072	CcSEcCtD
Enalapril—SLC22A7—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000504	0.00342	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000504	0.00342	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000504	0.00342	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.00049	0.00332	CbGpPWpGaD
Enalapril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000477	0.00324	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000476	0.00323	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000467	0.00317	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—UGDH—liver cancer	0.000465	0.00315	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—IL12B—liver cancer	0.000464	0.00315	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000448	0.00304	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000448	0.00304	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000435	0.00295	CbGpPWpGaD
Enalapril—CYP3A4—Tryptophan metabolism—CYP2E1—liver cancer	0.000425	0.00288	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000424	0.00287	CbGpPWpGaD
Enalapril—ABCB1—HIF-1-alpha transcription factor network—HMOX1—liver cancer	0.00042	0.00285	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000415	0.00281	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.00041	0.00278	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000409	0.00277	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000398	0.0027	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000398	0.0027	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000396	0.00268	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.00039	0.00265	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000376	0.00255	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000374	0.00254	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000374	0.00254	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—MYO5B—liver cancer	0.000364	0.00247	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.000364	0.00247	CbGpPWpGaD
Enalapril—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.000356	0.00241	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—FST—liver cancer	0.000355	0.00241	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000354	0.0024	CbGpPWpGaD
Enalapril—ABCB1—HIF-1-alpha transcription factor network—TERT—liver cancer	0.000345	0.00234	CbGpPWpGaD
Enalapril—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.000344	0.00233	CbGpPWpGaD
Enalapril—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.000339	0.0023	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—IGF2—liver cancer	0.000327	0.00222	CbGpPWpGaD
Enalapril—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	0.000305	0.00207	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000302	0.00205	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—UGDH—liver cancer	0.000302	0.00205	CbGpPWpGaD
Enalapril—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000294	0.00199	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—EPT1—liver cancer	0.000284	0.00192	CbGpPWpGaD
Enalapril—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000279	0.00189	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—liver cancer	0.000276	0.00187	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—NR1H4—liver cancer	0.000272	0.00184	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—liver cancer	0.000271	0.00184	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—TAT—liver cancer	0.000269	0.00182	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—GSTA3—liver cancer	0.000267	0.00181	CbGpPWpGaD
Enalapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—liver cancer	0.000265	0.0018	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000264	0.00179	CbGpPWpGaD
Enalapril—SLC22A7—SLC-mediated transmembrane transport—ALB—liver cancer	0.000264	0.00179	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	0.000263	0.00179	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—CYCS—liver cancer	0.000257	0.00174	CbGpPWpGaD
Enalapril—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—liver cancer	0.000253	0.00172	CbGpPWpGaD
Enalapril—SLC15A1—SLC-mediated transmembrane transport—ALB—liver cancer	0.000249	0.00169	CbGpPWpGaD
Enalapril—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000247	0.00168	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—GSTA4—liver cancer	0.000244	0.00166	CbGpPWpGaD
Enalapril—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000244	0.00165	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—CYCS—liver cancer	0.000243	0.00165	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.000241	0.00163	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—F2—liver cancer	0.000239	0.00162	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.000238	0.00162	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.00023	0.00156	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—NAT2—liver cancer	0.000227	0.00154	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.000224	0.00152	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000223	0.00151	CbGpPWpGaD
Enalapril—SLC22A8—SLC-mediated transmembrane transport—ALB—liver cancer	0.000222	0.0015	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—CYCS—liver cancer	0.000216	0.00146	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000211	0.00143	CbGpPWpGaD
Enalapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—liver cancer	0.000203	0.00138	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—MMP2—liver cancer	0.000203	0.00138	CbGpPWpGaD
Enalapril—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.0002	0.00136	CbGpPWpGaD
Enalapril—ABCB1—HIF-1-alpha transcription factor network—JUN—liver cancer	0.000199	0.00135	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000198	0.00134	CbGpPWpGaD
Enalapril—SLCO1A2—SLC-mediated transmembrane transport—ALB—liver cancer	0.000197	0.00134	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—CYCS—liver cancer	0.000192	0.0013	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.00019	0.00129	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000188	0.00127	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000186	0.00126	CbGpPWpGaD
Enalapril—SLC22A6—SLC-mediated transmembrane transport—ALB—liver cancer	0.000185	0.00126	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—CPT1B—liver cancer	0.000183	0.00124	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—GLUL—liver cancer	0.000183	0.00124	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.000182	0.00123	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—PPARA—liver cancer	0.00018	0.00122	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—CYCS—liver cancer	0.00018	0.00122	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—liver cancer	0.000178	0.00121	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000178	0.0012	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—CASP3—liver cancer	0.000178	0.0012	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—IL2—liver cancer	0.000177	0.0012	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—NR1H4—liver cancer	0.000176	0.0012	CbGpPWpGaD
Enalapril—ABCB1—HIF-1-alpha transcription factor network—VEGFA—liver cancer	0.000174	0.00118	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—GSTA3—liver cancer	0.000173	0.00117	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—PPARA—liver cancer	0.00017	0.00116	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—ANXA2—liver cancer	0.00017	0.00116	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—ATP7B—liver cancer	0.00017	0.00116	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000167	0.00113	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000161	0.00109	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—GSTA4—liver cancer	0.000158	0.00107	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000157	0.00106	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—CTNNB1—liver cancer	0.000156	0.00106	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000155	0.00105	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—GSTA2—liver cancer	0.000154	0.00105	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—liver cancer	0.000153	0.00104	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—PPARA—liver cancer	0.000152	0.00103	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—VEGFA—liver cancer	0.000151	0.00102	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—GSTA1—liver cancer	0.000149	0.00101	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—CYP2E1—liver cancer	0.000148	0.001	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—NAT2—liver cancer	0.000147	0.000999	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	0.000146	0.00099	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000142	0.000961	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—ALDOB—liver cancer	0.000141	0.000958	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—TGFB1—liver cancer	0.000138	0.000938	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—GGT1—liver cancer	0.000136	0.000922	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—CRABP1—liver cancer	0.000135	0.000914	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—PPARA—liver cancer	0.000135	0.000913	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—ALB—liver cancer	0.000134	0.00091	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	0.000134	0.000909	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	0.000132	0.000892	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—TNF—liver cancer	0.000129	0.000876	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—UGDH—liver cancer	0.000129	0.000876	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—ALB—liver cancer	0.000127	0.00086	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—PPARA—liver cancer	0.000127	0.000859	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—APC—liver cancer	0.000124	0.000843	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—GSTP1—liver cancer	0.000122	0.000828	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—EPT1—liver cancer	0.000121	0.000823	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000121	0.000823	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—RAF1—liver cancer	0.000121	0.000823	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	0.00012	0.000817	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—HPGDS—liver cancer	0.000118	0.000799	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000117	0.000794	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—TAT—liver cancer	0.000115	0.000781	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—RAF1—liver cancer	0.000115	0.000777	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—ALB—liver cancer	0.000113	0.000765	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—GSTM1—liver cancer	0.000112	0.000761	CbGpPWpGaD
Enalapril—ABCB1—HIF-1-alpha transcription factor network—AKT1—liver cancer	0.000111	0.000753	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	0.000111	0.000751	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000107	0.000723	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—CYP1A1—liver cancer	0.000106	0.000721	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000105	0.000714	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PSMD10—liver cancer	0.000105	0.000712	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PSMA4—liver cancer	0.000105	0.000712	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	0.000105	0.000711	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—GOT2—liver cancer	0.000102	0.000692	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—RAF1—liver cancer	0.000102	0.000691	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—ALB—liver cancer	0.0001	0.000679	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	9.76e-05	0.000662	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—CYP2E1—liver cancer	9.6e-05	0.000651	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—ALB—liver cancer	9.41e-05	0.000638	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	9.29e-05	0.00063	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—RAF1—liver cancer	9.05e-05	0.000614	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—CYCS—liver cancer	8.98e-05	0.000609	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	8.94e-05	0.000606	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—GOT1—liver cancer	8.81e-05	0.000598	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—GGT1—liver cancer	8.81e-05	0.000598	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	8.76e-05	0.000594	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	8.53e-05	0.000579	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	8.51e-05	0.000577	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—RAF1—liver cancer	8.51e-05	0.000577	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	8.45e-05	0.000573	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	8.25e-05	0.00056	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—CYCS—liver cancer	8.21e-05	0.000557	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	8.05e-05	0.000546	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—UGDH—liver cancer	7.95e-05	0.00054	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—GSTP1—liver cancer	7.91e-05	0.000537	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CPT1B—liver cancer	7.82e-05	0.000531	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GLUL—liver cancer	7.82e-05	0.000531	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—HMOX1—liver cancer	7.81e-05	0.00053	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—NR1H4—liver cancer	7.54e-05	0.000512	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—EPT1—liver cancer	7.48e-05	0.000507	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	7.43e-05	0.000504	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GSTA3—liver cancer	7.41e-05	0.000503	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—GSTM1—liver cancer	7.27e-05	0.000493	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	7.13e-05	0.000484	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—TAT—liver cancer	7.09e-05	0.000481	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—CYP1A1—liver cancer	6.89e-05	0.000468	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	6.84e-05	0.000464	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	6.82e-05	0.000463	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GSTA4—liver cancer	6.78e-05	0.00046	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GSTA2—liver cancer	6.61e-05	0.000448	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—MTHFR—liver cancer	6.43e-05	0.000436	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GSTA1—liver cancer	6.38e-05	0.000433	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	6.37e-05	0.000432	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	6.32e-05	0.000429	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PPARA—liver cancer	6.31e-05	0.000428	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—NAT2—liver cancer	6.3e-05	0.000428	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—ALDOB—liver cancer	6.04e-05	0.00041	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	5.81e-05	0.000394	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CRABP1—liver cancer	5.77e-05	0.000391	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	5.76e-05	0.000391	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	5.66e-05	0.000384	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	5.62e-05	0.000381	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PIK3CG—liver cancer	5.4e-05	0.000366	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PPARG—liver cancer	5.21e-05	0.000354	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—HPGDS—liver cancer	5.04e-05	0.000342	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CPT1B—liver cancer	4.82e-05	0.000327	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GLUL—liver cancer	4.82e-05	0.000327	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PIK3CD—liver cancer	4.75e-05	0.000322	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	4.74e-05	0.000322	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—ALB—liver cancer	4.69e-05	0.000318	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—NR1H4—liver cancer	4.65e-05	0.000315	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GSTA3—liver cancer	4.57e-05	0.00031	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PSMA4—liver cancer	4.49e-05	0.000305	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PSMD10—liver cancer	4.49e-05	0.000305	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GOT2—liver cancer	4.37e-05	0.000296	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	4.28e-05	0.000291	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GSTA4—liver cancer	4.18e-05	0.000283	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PIK3CB—liver cancer	4.14e-05	0.000281	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CYP2E1—liver cancer	4.11e-05	0.000279	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GSTA2—liver cancer	4.07e-05	0.000276	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GSTA1—liver cancer	3.93e-05	0.000266	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—NAT2—liver cancer	3.88e-05	0.000263	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	3.87e-05	0.000263	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CYCS—liver cancer	3.84e-05	0.000261	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GOT1—liver cancer	3.77e-05	0.000256	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GGT1—liver cancer	3.77e-05	0.000256	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—ALDOB—liver cancer	3.72e-05	0.000253	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CRABP1—liver cancer	3.55e-05	0.000241	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GSTP1—liver cancer	3.39e-05	0.00023	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—HMOX1—liver cancer	3.34e-05	0.000227	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GSTM1—liver cancer	3.11e-05	0.000211	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—HPGDS—liver cancer	3.1e-05	0.000211	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CYP1A1—liver cancer	2.95e-05	0.0002	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PSMD10—liver cancer	2.77e-05	0.000188	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PSMA4—liver cancer	2.77e-05	0.000188	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—MTHFR—liver cancer	2.75e-05	0.000187	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PPARA—liver cancer	2.7e-05	0.000183	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GOT2—liver cancer	2.69e-05	0.000183	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CYP2E1—liver cancer	2.53e-05	0.000172	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—PIK3CA—liver cancer	2.52e-05	0.000171	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CYCS—liver cancer	2.37e-05	0.000161	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GGT1—liver cancer	2.32e-05	0.000158	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GOT1—liver cancer	2.32e-05	0.000158	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PIK3CG—liver cancer	2.31e-05	0.000157	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PPARG—liver cancer	2.23e-05	0.000151	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GSTP1—liver cancer	2.09e-05	0.000142	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—AKT1—liver cancer	2.06e-05	0.00014	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—HMOX1—liver cancer	2.06e-05	0.00014	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PIK3CD—liver cancer	2.03e-05	0.000138	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—ALB—liver cancer	2.01e-05	0.000136	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GSTM1—liver cancer	1.92e-05	0.00013	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CYP1A1—liver cancer	1.82e-05	0.000123	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PIK3CB—liver cancer	1.77e-05	0.00012	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—MTHFR—liver cancer	1.7e-05	0.000115	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PPARA—liver cancer	1.66e-05	0.000113	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PIK3CG—liver cancer	1.42e-05	9.66e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PPARG—liver cancer	1.37e-05	9.33e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PIK3CD—liver cancer	1.25e-05	8.49e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—ALB—liver cancer	1.24e-05	8.39e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PIK3CB—liver cancer	1.09e-05	7.4e-05	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—PIK3CA—liver cancer	1.08e-05	7.33e-05	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—AKT1—liver cancer	8.82e-06	5.98e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—PIK3CA—liver cancer	6.65e-06	4.51e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—AKT1—liver cancer	5.44e-06	3.69e-05	CbGpPWpGaD
